U.S. Markets closed

3 Biotech Stocks Boasting Earnings Beats - and Healthy Outlooks

Bret Jensen

Fourth-quarter earnings season is winding down. It disclosed encouraging Phase 2 data for Nuplazid to treat major depressive disorder in October and will start two Phase 3 studies for that indication later this year.